Skip to content
Abstract
© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)
Related reading
-
Corrigendum to 'Comment on: History repeating: guidelines to address common problems in psychedelic science'.
Therapeutic advances in psychopharmacology
January 1, 2024
via PubMed
-
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
J Affect Disord
October 10, 2025
via PubMed
-
Erratum to "History repeating: guidelines to address common problems in psychedelic science".
Therapeutic advances in psychopharmacology
January 1, 2024
via PubMed
-
Corrigendum to: "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape".
Aust N Z J Psychiatry
May 18, 2026
via PubMed
-
Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis" [Journal of affective disorders, 322 (2023), 194-204].
J Affect Disord
April 3, 2025
via PubMed